SATLMEDIUM SIGNALFINANCIAL10-K

SATL showed meaningful improvement across key financial metrics with substantially reduced losses, revenue growth, and lower operating expenses.

The company demonstrated progress toward profitability with net losses declining dramatically while maintaining revenue growth momentum. The substantial reduction in current liabilities and overall debt burden indicates improved financial stability and potentially better working capital management.

Comparing 2026-03-19 vs 2025-03-26View on EDGAR →
FINANCIAL ANALYSIS

SATL's financial performance improved notably across most metrics, with net losses substantially reduced while revenue grew by 38% to $17.7M. Operating expenses declined meaningfully with R&D spending down 33% and SG&A costs reduced by 22%, contributing to improved operating performance. The balance sheet strengthened with current liabilities falling 35% and total liabilities declining 21%, while the company maintained modest investment in growth through higher capital expenditures.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+95.9%
-$116.3M-$4.8M

Net income grew 95.9% — bottom-line growth signals improving overall business health.

Capital Expenditure
Cash Flow
+46.4%
$5.0M$7.4M

Capital expenditure jumped 46.4% — major investment cycle underway; assess returns on deployment.

Operating Income
P&L
+40.6%
-$52.2M-$31.0M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Revenue
P&L
+37.6%
$12.9M$17.7M

Strong top-line growth of 37.6% — accelerating demand or successful expansion into new markets.

Current Liabilities
Balance Sheet
-35%
$34.6M$22.5M

Current liabilities reduced — improved short-term financial position and working capital health.

R&D Expense
P&L
-33.3%
$7.5M$5.0M

R&D spending cut 33.3% — could signal cost discipline or concerning reduction in innovation investment.

Operating Cash Flow
Cash Flow
+25.1%
-$35.9M-$26.9M

Operating cash flow grew 25.1% — strong conversion of earnings to cash, healthy business fundamentals.

SG&A Expense
P&L
-22%
$33.0M$25.7M

SG&A reduced 22% — improved cost efficiency or headcount reduction improving operating margins.

Total Liabilities
Balance Sheet
-20.9%
$114.7M$90.8M

Liabilities reduced 20.9% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-03-19
PRIOR — 2025-03-26
ADDED
As of March 13, 2026, there were 132,475,998 shares of Class A common stock, 10,582,641 shares of Class B common stock, and 49,184,815 warrants to purchase Class A common stock outstanding.
The Proxy Statement will be filed within 120 days of the registrant s fiscal year ended December 31, 2025.
MARKET FOR REGISTRANT S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 57 ITEM 6.
MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 58 ITEM 7A.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 115 ITEM 9A.
+7 more — sign up free →
REMOVED
As of March 14, 2025, there were 83,474,479 shares of Class A common stock, 13,582,642 shares of Class B common stock, and 49,184,815 warrants to purchase Class A common stock outstanding.
MARKET FOR REGISTRANT S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 58 ITEM 6 .
MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 58 ITEM 7 A .
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 115 ITEM 9 A .
EXECUTIVE COMPENSATION 122 ITEM 1 2 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 126 ITEM 1 3 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 128 ITEM 1 4 .
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →